Solid Biosciences Inc. Quarterly Nonoperating Income (Expense) in USD from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Solid Biosciences Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2017 to Q2 2024.
  • Solid Biosciences Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $2.72M, a 22.7% increase year-over-year.
  • Solid Biosciences Inc. Nonoperating Income (Expense) for the twelve months ending June 30, 2024 was $9.34M, a 61.6% decline year-over-year.
  • Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2023 was $8.24M, a 59.8% decline from 2022.
  • Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2022 was $20.5M, a 30917% increase from 2021.
  • Solid Biosciences Inc. annual Nonoperating Income (Expense) for 2021 was $66K, a 43.1% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.34M $2.72M +$502K +22.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $8.84M $2.56M +$599K +30.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $8.24M $1.93M -$17.5M -90.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 $25.7M $2.13M +$1.41M +196% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $24.3M $2.21M +$1.92M +663% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $22.4M $1.96M +$1.92M +4355% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $20.5M $19.4M +$19.4M +46126% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 $1.1M $722K +$674K +1404% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $424K $290K +$300K Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $124K $44K +$58K Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $66K $42K +$58K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-13
Q3 2021 $8K $48K +$68K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$60K -$10K +$3K +23.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$63K -$14K -$179K -108% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-27
Q4 2020 $116K -$16K -$485K -103% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $601K -$20K -$482K -104% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-03
Q2 2020 $1.08M -$13K -$457K -103% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $1.54M $165K -$555K -77.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $2.1M $469K +$4K +0.86% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-14
Q3 2019 $2.09M $462K +$332K +255% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.76M $444K +$246K +124% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.51M $720K +$624K +650% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 $889K $465K -$209K -31% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 $1.1M $130K -$61K -31.9% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $1.16M $198K -$378K -65.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $1.54M $96K -$142K -59.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-13
Q4 2017 $1.68M $674K Oct 1, 2017 Dec 31, 2017 10-K 2020-03-12
Q3 2017 $191K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $576K Mar 30, 2017 Jun 30, 2017 10-Q 2018-08-10
Q1 2017 $238K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.